Request for Information (RFI) on market capability, indicative timelines and costs for a feasibility study for the CSIR CDMO facility

In short

The CSIR is seeking information for a feasibility study for a national, open-access, multipurpose pharmaceutical and vaccine development and manufacturing facility (CDMO-like). The study will define, test, and cost the investment, preparing it for funding consideration. It will cover aspects like manufacturing scope (vaccines, biologics, APIs), enabling capabilities (analytical, quality control, warehousing), and key project principles (modular implementation, cGMP compliance).